{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:26:16Z","timestamp":1793057176070,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejogrb.2025.114093","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:12:28Z","timestamp":1749557548000},"page":"114093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["GnRH analogues and dienogest for second line treatment of endometriosis-associated pain: a systematic review, meta-analysis, and network meta-analysis"],"prefix":"10.1016","volume":"312","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8392-8928","authenticated-orcid":false,"given":"Aharon","family":"Dick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Matok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einat","family":"Gutman-Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama","family":"Lessans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri P.","family":"Dior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ejogrb.2025.114093_b0005","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMra1810764","article-title":"Endometriosis","volume":"382","author":"Zondervan","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114093_b0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1056\/NEJMra0804690","article-title":"Endometriosis","volume":"360","author":"Bulun","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejogrb.2025.114093_b0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41574-019-0245-z","article-title":"Rethinking mechanisms, diagnosis and management of endometriosis","volume":"15","author":"Chapron","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"22","key":"10.1016\/j.ejogrb.2025.114093_b0020","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.3390\/ijms20225615","article-title":"The pathogenesis of endometriosis: molecular and cell biology insights","volume":"20","author":"Lagan\u00e0","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114093_b0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/03007995.2020.1744120","article-title":"Use of dienogest in endometriosis: a narrative literature review and expert commentary","volume":"36","author":"Murji","year":"2020","journal-title":"Curr Med Res Opin"},{"issue":"13","key":"10.1016\/j.ejogrb.2025.114093_b0030","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.3390\/ijerph17134683","article-title":"The burden of endometriosis on women's lifespan: a narrative overview on quality of life and psychosocial wellbeing","volume":"17","author":"Della Corte","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ejogrb.2025.114093_b0035","article-title":"ESHRE guideline: endometriosis","volume":"2","author":"Becker","year":"2022","journal-title":"Hum Reprod Open"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114093_b0040","doi-asserted-by":"crossref","first-page":"398","DOI":"10.12891\/ceog4720.2019","article-title":"Long-term treatment of endometriosis with dienogest for up to five years","volume":"46","author":"Takagi","year":"2019","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.114093_b0045","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3109\/09513590.2014.911279","article-title":"Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis","volume":"30","author":"Miyashita","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2025.114093_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008475","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","volume":"12","author":"Brown","year":"2010","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.ejogrb.2025.114093_b0055","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","volume":"2","author":"Prentice","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2025.114093_b0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2013.12.001","article-title":"Suppression of the hypothalamic-pituitary-gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRH receptor knock-in mice","volume":"723","author":"Nakata","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"10343","key":"10.1016\/j.ejogrb.2025.114093_b0065","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(22)00622-5","article-title":"Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) [published correction appears in Lancet. 2022 Aug 27;400(10353):660]","volume":"399","author":"Giudice","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114093_b0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.fertnstert.2020.02.114","article-title":"Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial","volume":"114","author":"Donnez","year":"2020","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114093_b0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa1700089","article-title":"Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist","volume":"377","author":"Taylor","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2025.114093_b0100","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"10.1016\/j.ejogrb.2025.114093_b0080","unstructured":"https:\/\/www.campbellcollaboration.org\/escalc\/equations.php."},{"key":"10.1016\/j.ejogrb.2025.114093_b0085","unstructured":"Rucker G, Schwarzer G, Krahn U, Konig J. Network Meta-analysis using frequents methods. Available at: https:\/\/cran.r-project.org\/ web\/packages\/netmeta\/netmeta.pdf."},{"key":"10.1016\/j.ejogrb.2025.114093_b0090","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.ejogrb.2025.114093_b0105","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14817.1","article-title":"Endometriosis: advances and controversies in classification,pathogenesis, diagnosis, and treatment","volume":"8","author":"Rolla","year":"2019","journal-title":"F1000Res."},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114093_b0110","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00404-022-06862-0","article-title":"Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis","volume":"308","author":"Xin","year":"2023","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114093_b0115","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.fertnstert.2022.08.856","article-title":"Oral gonadotropin-releasing hormone antagonists for treating endometriosis-associated pain: a systematic review and network meta- analysis","volume":"118","author":"Yan","year":"2022","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114093_b0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.esxm.2020.01.002","article-title":"Deep dyspareunia, superficial dyspareunia, and infertility concerns among women with endometriosis: a cross-sectional study","volume":"8","author":"Wahl","year":"2020","journal-title":"Sex Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114093_b0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s13224-018-1119-3","article-title":"Dienogest versus leuprolide acetate for recurrent pelvic pain following laparoscopic treatment of endometriosis","volume":"68","author":"Abdou","year":"2018","journal-title":"J Obstet Gynaecol India"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114093_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.55561\/ajhr.v2i1.73","article-title":"Efficacy of dienogest on pelvic pain and dyspareunia: comprehensive meta-analysis and systematic review","volume":"2","author":"Sutrisno","year":"2023","journal-title":"Asian J Health Res"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.114093_b0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1701-2163(16)30728-9","article-title":"Prevalence of primary dysmenorrhea in Canada","volume":"27","author":"Burnett","year":"2005","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114093_b0140","first-page":"934","article-title":"Conscious pain mapping by laparoscopy in women with chronic pelvic pain","volume":"96","author":"Howard","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114093_b0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.fertnstert.2007.12.080","article-title":"Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis\u2013a randomized, double-blind, multicenter, controlled trial","volume":"91","author":"Harada","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.114093_b0150","unstructured":"Medicines Evaluation Board (Netherlands). Visanne (dienogest 2 mg tablet): summary of product characteristics [online]. Available from URL: http:\/\/db.cbg meb.nl\/IBteksten\/h104058.pdf."},{"issue":"4 Suppl 1","key":"10.1016\/j.ejogrb.2025.114093_b0160","first-page":"197","article-title":"An evidence-based review of elagolix for the treatment of pain secondary to endometriosis","volume":"50","author":"Urits","year":"2020","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114093_b0165","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/ijgo.15975","article-title":"Adenomyosis: a potential cause of surgical failure in treating dyspareunia in rectovaginal septum endometriosis","volume":"168","author":"Mercorio","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114093_b0170","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.fertnstert.2017.07.021","article-title":"Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study","volume":"108","author":"Osuga","year":"2017","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114093_b0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.rbmo.2021.09.019","article-title":"Treatment of symptomatic uterine adenomyosis with linzagolix, an oral gonadotrophin-releasing hormone antagonist: a pilot study","volume":"44","author":"Donnez","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2025.114093_b0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/IJWH.S5633","article-title":"Dienogest in long-term treatment of endometriosis","volume":"3","author":"Schindler","year":"2011","journal-title":"Int J Womens Health"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.114093_b0185","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jog.13023","article-title":"Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis","volume":"42","author":"Takaesu","year":"2016","journal-title":"J Obstet Gynaecol Res"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.114093_b0190","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/09513590.2021.1929151","article-title":"Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial","volume":"37","author":"Ceccaroni","year":"2021","journal-title":"Gynecol Endocrinol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525003690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525003690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T14:27:38Z","timestamp":1753453658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525003690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":36,"alternative-id":["S0301211525003690"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114093","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GnRH analogues and dienogest for second line treatment of endometriosis-associated pain: a systematic review, meta-analysis, and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114093"}}